Find stats on top websites
Industry Landscape
The Remote Patient Monitoring (RPM) industry is experiencing rapid growth, driven by technological advancements, rising chronic disease prevalence, and a push for value-based care. It's shifting towards more integrated, AI-powered, and contactless solutions, improving patient outcomes and operational efficiency while addressing staffing shortages and enhancing patient comfort and privacy. Regulatory support and increasing adoption across various care settings further fuel its expansion.
Total Assets Under Management (AUM)
Remote Patient Monitoring Market Size in United States
~Approximately 5.2 billion USD
(23.6% CAGR)
Growth is driven by:
- Increased adoption of telehealth.
- Rising prevalence of chronic diseases.
- Technological advancements and favorable reimbursement policies.
Total Addressable Market
117.1 billion USD
Market Growth Stage
Pace of Market Growth
Emerging Technologies
Edge AI for Real-time Analytics
Processing AI algorithms directly on monitoring devices to enable immediate insights and alerts without constant cloud dependency.
Explainable AI (XAI) in Diagnostics
Developing AI models that not only predict but also provide transparent reasoning for their diagnostic recommendations, enhancing trust and clinical adoption.
Haptic Feedback & Biometric Interfacing
Integrating haptic feedback with biometric data to create more intuitive and responsive patient-monitoring systems, potentially for non-invasive interventions or alerts.
Impactful Policy Frameworks
CMS Physician Fee Schedule (PFS) Final Rule for 2024
The Centers for Medicare & Medicaid Services (CMS) finalized changes in the 2024 Physician Fee Schedule, continuing to expand coverage and reimbursement for remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) services.
This policy directly impacts Neteera by solidifying and expanding reimbursement avenues for their RPM services, encouraging broader adoption among healthcare providers.
FDA's Digital Health Software Precertification (Pre-Cert) Program (Ongoing Evolution)
While not a new final rule, the FDA continues to evolve its approach to digital health, particularly for software as a medical device (SaMD), aiming for a more streamlined regulatory pathway for innovative, low-risk digital health technologies.
This regulatory evolution may streamline future clearances for Neteera's evolving software capabilities and new product iterations, accelerating market access.
Health Insurance Portability and Accountability Act (HIPAA) Enforcement Trends (Ongoing)
Ongoing enforcement and interpretation of HIPAA by the Office for Civil Rights (OCR) continues to emphasize the importance of robust data security and privacy measures for Protected Health Information (PHI) in digital health solutions.
Neteera's strong emphasis on HIPAA and SOC 2 compliance is critical, as heightened enforcement ensures trust and mandates their continued adherence to stringent data security practices, a key differentiator.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
